Literature DB >> 32780538

Superparamagnetic iron oxide nanoparticles promote ferroptosis of ischemic cardiomyocytes.

Hao Zheng1, Jieyun You1, Xiaobo Yao1, Qizheng Lu1, Wei Guo1, Yunli Shen1.   

Abstract

Entities:  

Keywords:  cardiotoxicity; ferroptosis; mitochondria; superparamagnetic iron oxide nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 32780538      PMCID: PMC7521151          DOI: 10.1111/jcmm.15722

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


× No keyword cloud information.

INTRODUCTION AND BACKGROUND

Superparamagnetic iron oxide nanoparticles (SPION) have been widely used in the diagnosis and treatment for cardiovascular diseases. , , , , , Correspondingly, the myocardial tissue safety of SPION is becoming a bottleneck to seriously restrict its clinical translation. In recent years, in vitro and in vivo experiments have confirmed that SPION‐induced oxidative stress of normal myocardium in mice, leading to myocardial cell injury, apoptosis or necrosis. , , More alarmingly, SPION applied to ischemic myocardium could accumulate in the target sites for a long time with high concentration, , , thereby probably further aggravating oxidative stress injury and cardiomyocytes death. , So far, however, the specific molecular mechanism of cardiotoxicity of SPION remains unclear. Previous studies have reported that SPION‐induced apoptosis of murine macrophage (J774) cells and necrosis of human endothelial cells. SPION can selectively induce autophagy‐mediated cell death of human cancer cells (A549). After SPION pre‐treatment, H9C2 cardiomyocytes were exposed to acrolein or H2O2, leading to reactive oxygen species (ROS) dependent cell necrosis. Our in vitro experiment showed that SPION significantly increased oxidative stress damage to overactivate autophagy and endoplasmic reticulum stress, eventually resulting in cardiomyocyte apoptosis. Furthermore, SPION could elicit IL‐1βrelease and pyroptosis in macrophages, especially with the octapod and plate morphology. Notably, it has been recently reported that sorafenib or cisplatin assembled into nano‐devices containing SPION, which are phagocytized by tumour cells and degraded into free divalent iron to accelerate Fenton reaction, leading to the lipid peroxidation burst to promote ferroptosis of tumour cells. , Taken together, SPION can induce apoptosis, necrosis, autophagy, pyroptosis or ferroptosis in vitro and in vivo studies. The discrepancy may be attributed to distinct cell types and experiments design. It has already been well documented that the toxicity of SPION is mainly due to its degradation and release of free iron to catalyse Fenton reaction, leading to oxidative stress by a large number of ROS generation. , Then, what is the downstream molecular mechanism of SPION mediated cardiotoxicity? Ferroptosis is a novel form of regulated cell death characterized by the iron‐dependent accumulation of lipid peroxides to lethal levels, which is morphologically, biochemically, and genetically distinct from apoptosis, necroptosis and autophagy. Recent studies found that ferroptosis is not only an important pathological mechanism in the case of circulating iron overload of hemochromatosis, but also a key molecular mechanism of cellular iron overload in doxorubicin (DOX) induced cardiomyopathy. DOX induced mitochondria iron overload by down‐regulating ABCB8, a mitochondrial protein that facilitates iron export, to elicit lipid peroxidation and mitochondria dysfunction, eventually causing cardiomyocytes ferroptosis. Mice that were subjected to 30 minutes of myocardial ischemia followed by 24 hours of reperfusion had significantly higher levels of cardiac non‐heme iron, cardiac ferritin H, ferritin L and Ptgs2 mRNA. Both ferroptosis inhibitor Ferrostatin‐1 (Fer‐1) and iron chelator Dexrazoxane (DXZ) pre‐treatment significantly reduced I/R‐induced cardiac remodelling and fibrosis, indicating that ischemia‐reperfusion could also induce cardiomyocytes iron overload to cause ferroptosis and subsequent left ventricular remodelling. Myocardial haemorrhage is a frequent complication after successful myocardial reperfusion, , which is associated with residual myocardial iron in post‐myocardial infarction (MI) patients received reperfusion therapy. It is reasonable to infer that this iron accumulation has a potential to generate excessive ROS and trigger pathological events such as ferroptosis. A previous study also confirmed that ferroptosis is a significant type of cell death in cardiomyocytes; moreover, mechanistic target of rapamycin (mTOR) was found to play an important role in protecting cardiomyocytes against excess iron and ferroptosis by regulating ROS production. In addition, glutathione peroxidase 4 (GPX4), which protects cells from ferroptosis, was down‐regulated in the early and middle stages of MI mouse model, suggesting that ferroptosis during MI was in part due to a reduction in GPX4 protein. Even though signalling pathways of ferroptosis in cardiovascular diseases is not yet well characterized, it has been confirmed that ischemia‐reperfusion (I/R) could induce mitochondrial iron overload in cardiomyocytes rather than the increase of iron content in cytoplasm. In this study, mice treated with 2,2′‐bipyridyl (BPD), which has high membrane permeability and thus is able to access mitochondria, had demonstrated protective effects on I/R myocardium, while deferoxamine (DFO) failed to protect mice against I/R damage due to poor penetrance into mitochondria. Notably, overexpression of ABCB8 in cardiomyocytes in mice reduces mitochondrial iron and protects against I/R damage, suggesting that ABCB8 might play an important role in maintaining iron homeostasis in myocardial mitochondria and regulating ferroptosis after I/R injury. Thus, it is not difficult to speculate that SPION could aggravate mitochondrial iron load in I/R myocardium. SPION applied in ischemic myocardium could be directly degraded by cardiomyocytes, leading to severe mitochondrial iron overload. We detected prominently mitochondrial lipid peroxidation (malondialdehyde, MDA), mitochondrial membrane potential (MMP) loss and ATP depletion at 24 hours and 4 weeks after SPION injected into the peri‐infarcted zones of myocardial ischemia‐reperfusion rats compared with the control group (all P < .01). We found that iron content of mitochondria was significantly higher than that in the control group (P < .001), and the distorted mitochondria were observed by transmission electron microscopy in the SPION group, suggesting that SPION have the potential to destroy mitochondrial structure and function by inducing mitochondria iron overload (data not published). Mitochondria are the major site of iron metabolism and ROS production, thereby cardiomyocytes iron accumulation is especially prone to induce mitochondria iron overload to trigger mitochondrial oxidative damage. Based on the above results, we speculate that SPION might further promote ferroptosis to aggravate left ventricular remodelling and cardiac deterioration by inducing severe mitochondria iron overload to promote lipid peroxidation burst.

HYPOTHESIS

To summarize, we speculate that SPION applied to ischemic myocardium could exacerbate cardiomyocytes ferroptosis to worsen left ventricular negative remodelling through inducing mitochondria iron overload to catalyse sustained Fenton reaction, eliciting lipid peroxidation burst(as shown in Figure 1). This hypothesis needs to be verified by animal experiments. Firstly, the mitochondrial iron metabolism, lipid peroxidation, morphology and function of mitochondria and ferroptosis should be carefully detected after SPION injected into the peri‐infarcted zones of myocardial ischemia‐reperfusion rats. Secondly, the rat models of myocardial ischemia‐reperfusion were randomly divided into different groups to, respectively, treated with apoptosis inhibitor, necrosis inhibitor, autophagy inhibitor and ferroptosis inhibitor, in order to verify whether ferroptosis play a pivotal role in cardiomyocytes death induced by SPION. Thirdly, SPION were injected into the myocardium of I/R mice model, in which Mlkl −/− or Fadd −/− Mlkl −/− mice were employed to respectively block the pathways of myocardial cell necroptosis or apoptosis, in order to further illustrate whether ferroptosis is the main pathway of SPION‐induced cardiomyocytes death. Fourthly, developing SPION modified by mitochondrial iron chelator or mitochondrial‐targeted antioxidant, the effects of two strategies to improve the myocardial safety of SPION should be comprehensively investigated in vitro and in vivo experiments, potentially promoting the clinical transformation of SPION in cardiovascular field.
FIGURE 1

SPION were internalized into cardiomyocytes and further degraded into free ferrous iron in lysosomes. The free ferrous iron entered into mitochondria, resulting in lipid peroxidation of mitochondria to trigger ferroptosis in cardiomyocytes by a large amount of ROS produced via Fenton reaction

SPION were internalized into cardiomyocytes and further degraded into free ferrous iron in lysosomes. The free ferrous iron entered into mitochondria, resulting in lipid peroxidation of mitochondria to trigger ferroptosis in cardiomyocytes by a large amount of ROS produced via Fenton reaction

IMPLICATION

The cardiotoxicity of SPION limits its diagnostic or therapeutic application in the cardiovascular field. It is helpful to promote the clinical transformation of SPION in cardiovascular field through rescuing the key target of SPION‐induced cardiomyocyte ferroptosis to improve the myocardial tissue safety. If our hypothesis is true, given that SPION mainly induce mitochondria iron overload of ischemic cardiomyocytes to catalyse lipid peroxidation and exacerbate ferroptosis, and then it is expected to significantly inhibit ferroptosis induced negative remodelling of ischemic myocardium by mitochondrial iron chelator or mitochondrial‐targeted antioxidant peptide modifying SPION to effectively protect mitochondria.

CONFLICT OF INTEREST

The authors confirm that there are no conflicts of interest.
  30 in total

1.  Superparamagnetic iron oxide nanoparticles exacerbate the risks of reactive oxygen species-mediated external stresses.

Authors:  Cheng Luo; Yan Li; Liang Yang; Xun Wang; Jiangang Long; Jiankang Liu
Journal:  Arch Toxicol       Date:  2014-05-22       Impact factor: 5.153

2.  Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes.

Authors:  Yuichi Baba; Jason K Higa; Briana K Shimada; Kate M Horiuchi; Tomohiro Suhara; Motoi Kobayashi; Jonathan D Woo; Hiroko Aoyagi; Karra S Marh; Hiroaki Kitaoka; Takashi Matsui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-10       Impact factor: 4.733

3.  Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation.

Authors:  Yoshihiko Ichikawa; Mohsen Ghanefar; Marina Bayeva; Rongxue Wu; Arineh Khechaduri; Sathyamangla V Naga Prasad; R Kannan Mutharasan; Tejaswitha Jairaj Naik; Hossein Ardehali
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

Review 4.  Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.

Authors:  Richard Gordan; Suwakon Wongjaikam; Judith K Gwathmey; Nipon Chattipakorn; Siriporn C Chattipakorn; Lai-Hua Xie
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

5.  Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles.

Authors:  Mohd Imran Khan; Akbar Mohammad; Govil Patil; S A H Naqvi; L K S Chauhan; Iqbal Ahmad
Journal:  Biomaterials       Date:  2011-11-17       Impact factor: 12.479

6.  Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress.

Authors:  Saba Naqvi; Mohammad Samim; Mz Abdin; Farhan Jalees Ahmed; An Maitra; Ck Prashant; Amit K Dinda
Journal:  Int J Nanomedicine       Date:  2010-11-16

7.  Evaluation of iron oxide nanoparticle biocompatibility.

Authors:  Amel Hanini; Alain Schmitt; Kamel Kacem; François Chau; Souad Ammar; Julie Gavard
Journal:  Int J Nanomedicine       Date:  2011-04-14

8.  Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment-Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling.

Authors:  Heerajnarain Bulluck; Stefania Rosmini; Amna Abdel-Gadir; Steven K White; Anish N Bhuva; Thomas A Treibel; Marianna Fontana; Manish Ramlall; Ashraf Hamarneh; Alex Sirker; Anna S Herrey; Charlotte Manisty; Derek M Yellon; Peter Kellman; James C Moon; Derek J Hausenloy
Journal:  Circ Cardiovasc Imaging       Date:  2016-10       Impact factor: 7.792

9.  Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer.

Authors:  Mangmang Sang; Renjie Luo; Yidan Bai; Jun Dou; Zhongtao Zhang; Fulei Liu; Feng Feng; Jian Xu; Wenyuan Liu
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

Review 10.  Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide.

Authors:  Shirjel R Alam; Colin Stirrat; Jennifer Richards; Saeed Mirsadraee; Scott I K Semple; George Tse; Peter Henriksen; David E Newby
Journal:  J Cardiovasc Magn Reson       Date:  2015-09-18       Impact factor: 5.364

View more
  5 in total

Review 1.  Nanoparticles Targeting the Molecular Pathways of Heart Remodeling and Regeneration.

Authors:  Diana Gonciar; Teodora Mocan; Lucia Agoston-Coldea
Journal:  Pharmaceutics       Date:  2022-03-26       Impact factor: 6.525

Review 2.  Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle.

Authors:  Yue Huang; Jessica C Hsu; Hyun Koo; David P Cormode
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 3.  Ionizing Radiation-Induced Ferroptosis Based on Nanomaterials.

Authors:  Shenghong Zhang; Jiajia Zhang; Xin Fan; Hanhui Liu; Mengqin Zhu; Mengdie Yang; Xiaoyi Zhang; Han Zhang; Fei Yu
Journal:  Int J Nanomedicine       Date:  2022-08-06

4.  Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients.

Authors:  Na Zhang; Yangyang Wu; Yifan Wu; Lihong Wang; Jingfei Chen; Xiaosa Wang; Louisa S Chard Dunmall; Zhenguo Cheng; Yaohe Wang
Journal:  Cells       Date:  2022-07-15       Impact factor: 7.666

5.  Superparamagnetic iron oxide nanoparticles promote ferroptosis of ischemic cardiomyocytes.

Authors:  Hao Zheng; Jieyun You; Xiaobo Yao; Qizheng Lu; Wei Guo; Yunli Shen
Journal:  J Cell Mol Med       Date:  2020-08-11       Impact factor: 5.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.